[Form 4] Atlassian Corp Insider Trading Activity
Rhea-AI Filing Summary
Michael Cannon-Brookes, CEO and Co-Founder of Atlassian Corporation (TEAM), reported multiple sales of Class A common stock on 09/22/2025 under a Rule 10b5-1 trading plan adopted on 02/20/2025. The filings show six separate dispositions totaling 7,665 shares executed in multiple trades at weighted-average prices disclosed per lot. Following the reported transactions, the Reporting Person beneficially owned 45,990 shares indirectly through CBC Co Pty Limited as trustee for the Cannon-Brookes Head Trust. The Form 4 was signed by an attorney-in-fact on 09/23/2025 and indicates the sales were effected pursuant to the pre-established trading plan.
Positive
- Sales executed under a Rule 10b5-1 trading plan, indicating pre-established compliance procedures
- Full Form 4 disclosure with per-tranche weighted-average prices and an offer to provide trade details on request
- Indirect ownership disclosed (CBC Co Pty Limited as trustee for the Cannon-Brookes Head Trust), clarifying beneficial ownership
Negative
- Insider reduced holdings by 7,665 shares on 09/22/2025, lowering beneficial ownership to 45,990 shares
- Sales executed across price range from approximately $166.43 to $172.25, indicating disposals over varying market prices
Insights
TL;DR: Routine insider sales under a Rule 10b5-1 plan; transparent reporting but reduces insider stake modestly.
The transactions represent methodical disposals implemented under a documented 10b5-1 plan adopted on 02/20/2025. Total disclosed sales on 09/22/2025 equal 7,665 Class A shares executed across multiple trade blocks with weighted-average prices reported per lot. Such plans are commonly used to provide an affirmative defense to insider trading claims and to schedule liquidity. From an investor perspective, these sales are disclosure-compliant and not presented as opportunistic or single-block large trades; materiality is limited relative to total company float unless larger holdings exist outside this Form 4.
TL;DR: Proper procedural steps taken: 10b5-1 plan referenced, and the Form 4 discloses indirect ownership and executor signature.
The filing clearly identifies the reporting person’s roles (CEO, Director, ~10% owner) and that shares are held indirectly via a trust. The explicit citation of the 10b5-1 plan adoption date and the attorney-in-fact signature on 09/23/2025 support governance and compliance best practices. The disclosure includes weighted-average prices per tranche and offers to provide trade details on request, which strengthens transparency. No derivative transactions or amendments are reported.